We are live on ! Find out more
IE

Israel Englander Millennium Management

AUM $276B
1-Year Est. Return 44.8%
 

Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.

This Fund
S&P 500
This Quarter Est. Return
+6.92%
1 Year Est. Return
+44.8%
3 Year Est. Return
+127.22%
5 Year Est. Return
+155.52%
10 Year Est. Return
+768.06%
AUM
$65.6B
AUM Growth
+$9.58B
Cap. Flow
+$6.37B
Cap. Flow %
9.71%
Top 10 Hldgs %
7.83%
Holding
4,198
New
794
Increased
1,441
Reduced
1,175
Closed
737

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$208M
2
CXO
CONCHO RESOURCES INC.
CXO
+$177M
3
CCI icon
Crown Castle
CCI
+$168M
4
WMT icon
Walmart Inc
WMT
+$167M
5
ETR icon
Entergy
ETR
+$157M

Sector Composition

Rank Sector Weight
1 Financials 13.75%
2 Technology 13.18%
3 Healthcare 11.51%
4 Industrials 10.45%
5 Consumer Discretionary 9.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVS icon
776
CVS Health
CVS
$120B
$20.6M 0.03%
253,900
+180,693
+247% +$14.3M
KMT icon
777
Kennametal
KMT
$2.23B
$20.6M 0.03%
511,813
-1,025,256
-67% -$37.9M
KRG icon
778
Kite Realty
KRG
$5.26B
$20.6M 0.03%
+1,018,540
New +$20.4M
TROW icon
779
T. Rowe Price
TROW
$24B
$20.6M 0.03%
+227,327
New +$18.8M
GSK icon
780
GSK
GSK
$104B
$20.6M 0.03%
405,951
-1,869,822
-82% -$94.9M
HUN icon
781
Huntsman Corp
HUN
$1.68B
$20.6M 0.03%
749,934
+569,042
+315% +$15.2M
BAK icon
782
Braskem
BAK
$733M
$20.5M 0.03%
767,475
+311,782
+68% +$7.66M
PBH icon
783
Prestige Consumer Healthcare
PBH
$2.46B
$20.5M 0.03%
409,591
+263,330
+180% +$13.5M
XOM icon
784
CALL
ExxonMobil
XOM
$675B
$20.5M 0.03%
+250,000
New +$19.9M
MTCH icon
785
Match Group
MTCH
$9.58B
$20.5M 0.03%
882,597
+608,855
+222% +$12.3M
PODD icon
786
Insulet
PODD
$10.1B
$20.4M 0.03%
+370,485
New +$20.2M
WEX icon
787
WEX
WEX
$6.93B
$20.3M 0.03%
181,188
-84,342
-32% -$9.14M
MYGN icon
788
Myriad Genetics
MYGN
$292M
$20.3M 0.03%
561,956
-850,615
-60% -$24.3M
AME icon
789
Ametek
AME
$55.6B
$20.3M 0.03%
307,632
-83,652
-21% -$5.29M
TX icon
790
Ternium
TX
$10.8B
$20.3M 0.03%
656,714
+469,140
+250% +$14.2M
IDCC icon
791
InterDigital
IDCC
$8.8B
$20.3M 0.03%
275,312
+69,703
+34% +$5.1M
HEI.A icon
792
HEICO Corp Class A
HEI.A
$36.2B
$20.3M 0.03%
519,852
+244,813
+89% +$8.96M
REG icon
793
Regency Centers
REG
$14B
$20.3M 0.03%
326,586
+296,726
+994% +$19.1M
TMX
794
DELISTED
Terminix Global Holdings, Inc.
TMX
$20.2M 0.03%
645,878
+602,565
+1,391% +$17.8M
HTH icon
795
Hilltop Holdings
HTH
$2.22B
$20.2M 0.03%
775,903
+204,342
+36% +$5.13M
NFG icon
796
National Fuel Gas
NFG
$7.84B
$20.2M 0.03%
356,329
+66,205
+23% +$3.83M
OSIS icon
797
OSI Systems
OSIS
$3.36B
$20.1M 0.03%
220,074
+67,540
+44% +$5.49M
DEI icon
798
Douglas Emmett
DEI
$2B
$20M 0.03%
508,237
-1,220
-0.2% -$46.7K
EQNR icon
799
Equinor
EQNR
$101B
$20M 0.03%
995,017
+56,137
+6% +$1.04M
HIMX
800
Himax Technologies
HIMX
$2.34B
$20M 0.03%
1,827,646
-66,307
-4% -$602K

Similar funds

Israel Englander's Q3 2017 Portfolio in Review

As of Q3 2017, Israel Englander held 4,198 positions worth $65.6B, up 17% from $56.1B the previous quarter. Its ten largest holdings account for 7.8% of the portfolio.

Israel Englander deployed $6.37B of net new capital in Q3 2017, opening 794 new positions and adding to 1,441 existing holdings. Its largest new stake was Northern Trust: 1,591,041 shares worth $146M.

By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Gilead Sciences, an estimated $208M trimmed.

  • Israel Englander's largest Q3 2017 buy was Northern Trust: 1,591,041 shares worth $146M.
  • Israel Englander added most to Salesforce in Q3 2017, an estimated $208M increase.
  • Israel Englander's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $208M.
  • Israel Englander fully exited CONCHO RESOURCES INC. in Q3 2017, selling an estimated $177M.
  • Israel Englander's ten largest holdings make up 7.8% of its $65.6B portfolio in Q3 2017.
  • Israel Englander opened 794 new positions and closed 737 in Q3 2017.
  • Israel Englander's portfolio value rose 17% quarter-over-quarter to $65.6B.

Based on Millennium Management's 13F filing for Q3 2017, filed 14 Nov 2017.